Last price paid | 0.22 | |
Change | +15.79% [ +0.03 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 19.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 15.05.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +87.50% |
Year to date (YTD) | -33.33% |
1 month | +4.76% |
3 months | +4.76% |
1 year | +10.00% |
3 years | n.a. |
Issue price | 0.12 |
Underlying price on issue | 46.20 |
Premium | 0.03% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1250732992 |
Symbol | IBSWEZ |
Security | 125073299 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Basilea Pharmaceu N, CH0011432447 |
Underlying ISIN | CH0011432447 |
Funding level | 49.894700 |
Stop-loss level | 47.975200 |
Distance to stop-loss level | 20.24% |
Long/Short type | Short |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.05.2023 |
Premium | 3.15% |
Premium p.a. | n.a. |
Leverage | 3.55 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 9.994700 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
KUEHNE & NAGEL | 265.70 |
NOVARTIS N | 96.31 |
LOGITECH INT. | 80.64 |
Givaudan | 4'304.00 |
GEBERIT N | 565.00 |
Name | Price |
---|---|
Swiss Re | 106.05 |
ZURICH INSURANCE | 474.40 |
Alcon AG | 80.34 |
SWISSCOM N | 534.50 |
ROCHE GS | 279.90 |